URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

John Bisognano

Concepts (327)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hypertension
34
1998
300
14.340
Why?
Antihypertensive Agents
21
1998
82
8.620
Why?
Baroreflex
9
2006
22
5.790
Why?
Electric Stimulation Therapy
9
2006
28
5.170
Why?
Blood Pressure
13
2004
474
4.030
Why?
Carotid Sinus
6
2006
11
2.500
Why?
Drug Resistance
6
2006
101
1.780
Why?
Heart Failure
5
1996
389
1.730
Why?
Diuretics
4
2006
34
1.510
Why?
Humans
57
1993
36400
1.470
Why?
Fumarates
3
2008
19
1.430
Why?
Amides
3
2008
39
1.410
Why?
Angiotensin-Converting Enzyme Inhibitors
6
1998
51
1.390
Why?
Treatment Outcome
12
2004
2623
1.350
Why?
Electrodes, Implanted
6
2006
56
1.300
Why?
Renin-Angiotensin System
3
1999
20
1.190
Why?
Electrocardiography
5
2003
782
1.160
Why?
Amlodipine
2
2004
7
1.010
Why?
Hospitalization
2
2007
377
1.010
Why?
Life Style
2
2011
87
0.960
Why?
Angiotensin Receptor Antagonists
2
1998
11
0.920
Why?
Emergency Treatment
2
1999
34
0.870
Why?
Tobacco Use Cessation Products
1
2012
3
0.870
Why?
Acute Coronary Syndrome
1
2012
10
0.850
Why?
Sympathetic Nervous System
2
2006
115
0.840
Why?
Female
22
1997
19826
0.840
Why?
Heart Transplantation
2
1999
69
0.840
Why?
Male
24
1997
19713
0.840
Why?
Renin
2
2008
60
0.830
Why?
Plant Preparations
1
2011
2
0.820
Why?
Retrospective Studies
9
2004
2260
0.810
Why?
Patient Care
1
2012
40
0.810
Why?
Middle Aged
17
1997
9877
0.800
Why?
Implantable Neurostimulators
1
2011
2
0.800
Why?
Heart Neoplasms
2
2008
22
0.800
Why?
Dietary Supplements
1
2011
44
0.790
Why?
Smoking Cessation
1
2012
81
0.780
Why?
Community Health Services
1
2012
77
0.780
Why?
Sympathectomy
1
2011
21
0.780
Why?
Adrenergic beta-Antagonists
2
2007
175
0.770
Why?
Myocardial Ischemia
2
2007
127
0.770
Why?
Lymphoma, Large B-Cell, Diffuse
2
2008
78
0.740
Why?
Continuous Positive Airway Pressure
1
2010
8
0.730
Why?
Endocarditis
1
2010
11
0.730
Why?
Mitral Valve Insufficiency
1
2010
24
0.720
Why?
Arrhythmias, Cardiac
1
2012
248
0.720
Why?
Hypertension, Pregnancy-Induced
1
2009
4
0.720
Why?
Sleep Apnea, Obstructive
1
2010
16
0.720
Why?
Mitral Valve
1
2010
39
0.720
Why?
Catheter Ablation
1
2011
76
0.710
Why?
Calcium Channel Blockers
2
2007
69
0.710
Why?
Hemodynamics
2
2004
279
0.710
Why?
Thromboembolism
1
2010
44
0.710
Why?
Pressoreceptors
1
2009
11
0.690
Why?
Quality of Health Care
1
2012
207
0.690
Why?
Erythema Multiforme
1
2009
3
0.680
Why?
Metoprolol
1
2009
10
0.680
Why?
Circadian Rhythm
1
2009
85
0.670
Why?
Music
1
2009
20
0.670
Why?
Staphylococcus aureus
1
2010
110
0.660
Why?
Diterpenes, Kaurane
1
2008
1
0.660
Why?
Comorbidity
3
2003
374
0.650
Why?
Sweetening Agents
1
2008
14
0.650
Why?
Pregnancy Outcome
1
2009
136
0.650
Why?
Aged
13
1998
7272
0.640
Why?
Smoking
1
2012
390
0.630
Why?
Deglutition Disorders
1
2008
17
0.630
Why?
Heart Diseases
1
2009
145
0.610
Why?
Trans Fatty Acids
1
2007
2
0.600
Why?
Echocardiography
5
1998
232
0.600
Why?
Natriuretic Peptide, Brain
1
2007
11
0.600
Why?
Blood Urea Nitrogen
1
2007
43
0.600
Why?
Drugs, Generic
1
2007
10
0.590
Why?
Kidney
1
2011
582
0.590
Why?
Cardiac Output, Low
1
2007
16
0.590
Why?
Energy Intake
1
2007
60
0.590
Why?
Vascular Diseases
1
2007
70
0.570
Why?
Patient Care Planning
1
2007
71
0.570
Why?
Protein Precursors
1
2007
85
0.570
Why?
Receptors, Endothelin
1
2006
15
0.560
Why?
Health Policy
1
2007
82
0.560
Why?
Coronary Disease
2
2003
266
0.540
Why?
Ailanthus
1
2005
1
0.540
Why?
Hospital Costs
1
2006
33
0.540
Why?
Leukoaraiosis
1
2005
1
0.540
Why?
Myocarditis
1
2005
15
0.530
Why?
Geriatric Assessment
1
2007
150
0.530
Why?
Cardiovascular Diseases
2
2004
276
0.530
Why?
Coronary Vasospasm
1
2005
8
0.520
Why?
Tetrazoles
1
2004
12
0.510
Why?
Peptide Fragments
1
2007
301
0.510
Why?
Myocardium
3
1996
325
0.510
Why?
Valine
1
2004
32
0.510
Why?
Brain Ischemia
1
2005
79
0.490
Why?
Follow-Up Studies
4
2003
1857
0.470
Why?
Stroke
1
2005
117
0.460
Why?
Emergency Service, Hospital
1
2006
205
0.460
Why?
Drug Therapy, Combination
4
1998
390
0.460
Why?
Acute Disease
4
1999
580
0.440
Why?
Predictive Value of Tests
3
2008
601
0.430
Why?
Adult
11
1997
11345
0.430
Why?
Myocardial Infarction
2
2003
681
0.430
Why?
Time Factors
4
2007
3201
0.420
Why?
New York
3
2007
1282
0.410
Why?
Aged, 80 and over
5
1998
2513
0.390
Why?
Receptors, Adrenergic, beta-1
1
2000
1
0.380
Why?
Prognosis
3
2007
1080
0.380
Why?
Randomized Controlled Trials as Topic
3
2004
409
0.360
Why?
Parvovirus B19, Human
1
1999
5
0.360
Why?
Parvoviridae Infections
1
1999
11
0.350
Why?
Europe
2
2007
79
0.350
Why?
Erythropoietin
1
1999
27
0.350
Why?
Proto-Oncogene Proteins c-bcl-2
1
2000
119
0.340
Why?
Hypertension, Malignant
1
1999
6
0.340
Why?
Animals
7
2000
16270
0.340
Why?
Immunocompromised Host
1
1999
82
0.330
Why?
Stroke Volume
3
2007
161
0.330
Why?
Heart
1
2000
242
0.330
Why?
Ventricular Outflow Obstruction
1
1998
11
0.320
Why?
Tricuspid Valve
1
1998
18
0.320
Why?
Exercise
2
2008
182
0.320
Why?
Blood Pressure Monitoring, Ambulatory
2
2007
13
0.310
Why?
Subclavian Artery
1
1997
26
0.310
Why?
Survival Rate
2
2007
619
0.310
Why?
Risk Factors
3
2008
2318
0.300
Why?
Odds Ratio
2
2003
304
0.300
Why?
Double-Blind Method
2
2008
998
0.290
Why?
Biological Markers
3
2000
564
0.280
Why?
United States
3
2007
2630
0.280
Why?
Logistic Models
2
2008
578
0.280
Why?
Michigan
2
2003
19
0.270
Why?
Erythrocytes
2
1993
333
0.260
Why?
Echocardiography, Transesophageal
2
1998
54
0.260
Why?
Length of Stay
2
2006
280
0.250
Why?
Angiotensin II Type 1 Receptor Blockers
2
2004
9
0.250
Why?
Clinical Trials as Topic
2
2007
675
0.240
Why?
Protons
2
1993
79
0.240
Why?
Hydroxides
1
1993
25
0.230
Why?
Labetalol
2
1999
4
0.230
Why?
Emergencies
2
1999
77
0.220
Why?
Feasibility Studies
2
2004
205
0.220
Why?
Electric Power Supplies
1
2012
11
0.210
Why?
Social Marketing
1
2012
9
0.210
Why?
Education
1
2012
38
0.210
Why?
Breathing Exercises
1
2011
3
0.210
Why?
Confidence Intervals
1
2012
165
0.200
Why?
Program Development
1
2012
77
0.200
Why?
Cohort Studies
2
2009
969
0.190
Why?
Cooperative Behavior
1
2012
101
0.190
Why?
Program Evaluation
1
2012
205
0.190
Why?
Registries
1
2012
223
0.190
Why?
Severity of Illness Index
2
1999
919
0.190
Why?
Ventricular Function, Left
1
2011
98
0.190
Why?
Practice Guidelines as Topic
2
2010
304
0.190
Why?
Nafcillin
1
2010
2
0.180
Why?
Rhinitis, Allergic, Perennial
1
2010
5
0.180
Why?
Motivation
1
2012
159
0.180
Why?
Echocardiography, Doppler, Color
1
2010
16
0.180
Why?
Retinal Vessels
1
2010
38
0.180
Why?
Eclampsia
1
2009
7
0.180
Why?
Maternal Mortality
1
2009
9
0.180
Why?
Blood Pressure Determination
1
2009
19
0.180
Why?
Carotid Body
1
2009
9
0.180
Why?
Meta-Analysis as Topic
1
2010
35
0.180
Why?
Pre-Eclampsia
1
2009
27
0.180
Why?
Incidence
1
2012
679
0.180
Why?
Hypersensitivity
1
2010
44
0.180
Why?
Markov Chains
1
2009
36
0.180
Why?
Health Promotion
1
2012
152
0.170
Why?
Diastole
1
2009
27
0.170
Why?
Systole
1
2009
40
0.170
Why?
Monitoring, Physiologic
1
2009
102
0.170
Why?
Prenatal Care
1
2009
70
0.170
Why?
Takotsubo Cardiomyopathy
1
2009
3
0.170
Why?
Heart Atria
1
2009
71
0.170
Why?
Hydroxyzine
1
2009
3
0.170
Why?
Adrenal Cortex Neoplasms
1
2009
12
0.170
Why?
Histamine H1 Antagonists
1
2009
16
0.170
Why?
Periodicity
1
2009
41
0.170
Why?
Esophageal Neoplasms
1
2009
57
0.170
Why?
Pheochromocytoma
1
2009
38
0.170
Why?
Coronary Angiography
2
2005
91
0.170
Why?
Hypotension
1
2009
47
0.170
Why?
Treatment Failure
1
2009
130
0.170
Why?
Drug Evaluation, Preclinical
1
2008
79
0.160
Why?
Chi-Square Distribution
1
2009
333
0.160
Why?
Equipment Design
1
2009
247
0.160
Why?
Posture
1
2008
113
0.160
Why?
Placebos
1
2008
182
0.160
Why?
Carotid Arteries
1
2009
106
0.150
Why?
Kidney Diseases
1
2010
171
0.150
Why?
Proportional Hazards Models
1
2009
453
0.150
Why?
Health Status Indicators
1
2008
108
0.150
Why?
Diet, Fat-Restricted
1
2007
4
0.150
Why?
Diet, Sodium-Restricted
1
2007
13
0.150
Why?
Combined Modality Therapy
1
2009
486
0.150
Why?
Minoxidil
1
2007
3
0.150
Why?
Hospitals, Special
1
2007
8
0.150
Why?
Chlorthalidone
1
2007
5
0.150
Why?
Drug Costs
1
2007
26
0.150
Why?
Body Weight
1
2008
338
0.150
Why?
Sodium Chloride Symporter Inhibitors
1
2007
10
0.150
Why?
Evidence-Based Medicine
1
2009
199
0.150
Why?
Electric Stimulation
1
2007
228
0.150
Why?
Risk Reduction Behavior
1
2007
40
0.150
Why?
Ambulatory Care Facilities
1
2007
33
0.150
Why?
Patient Readmission
1
2007
42
0.150
Why?
Creatinine
1
2007
132
0.140
Why?
Video Games
1
2007
23
0.140
Why?
Receptors, Cell Surface
1
2008
215
0.140
Why?
Diabetes Complications
1
2007
66
0.140
Why?
Patient Admission
1
2007
83
0.140
Why?
Diet
1
2008
206
0.140
Why?
Risk
1
2007
358
0.140
Why?
Captopril
1
2006
14
0.140
Why?
Forecasting
1
2007
178
0.140
Why?
Metabolic Syndrome X
1
2007
58
0.140
Why?
Clonidine
1
2006
32
0.140
Why?
Multivariate Analysis
1
2008
531
0.140
Why?
Vasoconstriction
1
2006
42
0.140
Why?
Asthma
1
2010
294
0.140
Why?
Obesity
1
2010
335
0.140
Why?
Patient-Centered Care
1
2007
77
0.130
Why?
Treatment Refusal
1
2006
43
0.130
Why?
Heart Rate
1
2008
470
0.130
Why?
Anti-Bacterial Agents
1
2010
436
0.130
Why?
Patient Compliance
1
2007
171
0.130
Why?
Nitroglycerin
1
2005
19
0.130
Why?
Magnetic Resonance Imaging
2
2008
1010
0.130
Why?
Nerve Fibers, Myelinated
1
2005
38
0.130
Why?
Risk Assessment
1
2009
878
0.130
Why?
Isoproterenol
1
2004
79
0.130
Why?
Young Adult
1
2009
1074
0.120
Why?
Vasodilator Agents
1
2005
76
0.120
Why?
Prevalence
1
2007
541
0.120
Why?
Adrenergic beta-Agonists
1
2004
55
0.120
Why?
Disease Models, Animal
1
2009
973
0.120
Why?
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
2
1993
13
0.120
Why?
Graft Rejection
1
2005
130
0.120
Why?
Emergency Medical Services
1
2006
132
0.120
Why?
Transplantation, Homologous
1
2005
260
0.120
Why?
Dementia
1
2005
100
0.120
Why?
Pregnancy
1
2009
1962
0.120
Why?
Fatal Outcome
2
1997
109
0.120
Why?
Energy Metabolism
1
2004
137
0.120
Why?
Troponin I
1
2003
6
0.120
Why?
Chlorides
2
1993
121
0.120
Why?
Creatine Kinase
1
2003
58
0.120
Why?
Patient Education as Topic
1
2005
219
0.110
Why?
Cardiovascular Agents
1
2003
25
0.110
Why?
Syndrome
1
2003
210
0.110
Why?
Cerebral Cortex
1
2005
250
0.110
Why?
Sex Distribution
1
2003
154
0.110
Why?
Age Distribution
1
2003
216
0.110
Why?
Genetic Predisposition to Disease
1
2005
329
0.110
Why?
Disease Progression
1
2005
519
0.110
Why?
Reference Values
1
2003
441
0.100
Why?
Regression Analysis
1
2003
524
0.100
Why?
Diagnosis, Differential
2
1997
878
0.100
Why?
Rats
1
2009
4386
0.090
Why?
bcl-2-Associated X Protein
1
2000
56
0.090
Why?
Fenoldopam
1
1999
1
0.090
Why?
Nitroprusside
1
1999
32
0.080
Why?
Drug Monitoring
1
1999
36
0.080
Why?
Injections, Intravenous
1
1999
131
0.080
Why?
Infusions, Intravenous
1
1999
139
0.080
Why?
Adolescent
1
2008
4752
0.080
Why?
Aortitis
1
1997
1
0.080
Why?
Dyspnea
1
1997
13
0.080
Why?
Aortic Aneurysm, Thoracic
1
1997
13
0.080
Why?
Aneurysm, Infected
1
1997
11
0.080
Why?
Cough
1
1997
24
0.080
Why?
Proto-Oncogene Proteins
1
2000
297
0.080
Why?
Mice, Transgenic
1
2000
769
0.070
Why?
Brain
1
2005
1221
0.070
Why?
Heterogeneous-Nuclear Ribonucleoprotein D
1
1996
2
0.070
Why?
Streptococcus pyogenes
1
1997
102
0.070
Why?
Gene Expression
1
2000
756
0.070
Why?
Receptors, Adrenergic, beta
1
1996
69
0.070
Why?
Sodium
2
1993
302
0.070
Why?
Membrane Potentials
2
1993
343
0.070
Why?
Potassium
2
1993
306
0.070
Why?
Streptococcal Infections
1
1997
171
0.070
Why?
Chronic Disease
1
1997
530
0.070
Why?
Gramicidin
1
1994
2
0.060
Why?
Valinomycin
1
1994
15
0.060
Why?
RNA-Binding Proteins
1
1996
129
0.060
Why?
Postoperative Complications
1
1999
743
0.060
Why?
Ethoxzolamide
1
1993
2
0.060
Why?
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid
1
1993
9
0.060
Why?
Carbocyanines
1
1993
20
0.060
Why?
Apoptosis
1
2000
855
0.060
Why?
Body Water
1
1993
33
0.060
Why?
Sucrose
1
1993
85
0.060
Why?
Saline Solution, Hypertonic
1
1993
29
0.060
Why?
Benzothiazoles
1
1993
54
0.060
Why?
Indicators and Reagents
1
1993
114
0.060
Why?
Osmolar Concentration
1
1993
157
0.060
Why?
Hemoglobins
1
1993
94
0.060
Why?
Scattering, Radiation
1
1993
75
0.060
Why?
Light
1
1993
157
0.050
Why?
Gene Expression Regulation
1
1996
875
0.050
Why?
Sleep Apnea Syndromes
1
2010
17
0.050
Why?
Esophagogastric Junction
1
2009
8
0.040
Why?
Hypertension, Pulmonary
1
2010
28
0.040
Why?
Endoscopy, Gastrointestinal
1
2009
20
0.040
Why?
Quality-Adjusted Life Years
1
2009
50
0.040
Why?
Sex Characteristics
1
2010
142
0.040
Why?
Catecholamines
1
2009
80
0.040
Why?
RNA, Messenger
1
1996
1857
0.040
Why?
Cost-Benefit Analysis
1
2009
209
0.040
Why?
Mice
1
2000
6103
0.040
Why?
Sensitivity and Specificity
1
2009
905
0.030
Why?
Tomography, X-Ray Computed
1
2009
765
0.030
Why?
Oxygen Consumption
1
2004
206
0.030
Why?
Polyribosomes
1
1996
21
0.020
Why?
Muscle, Smooth
1
1996
118
0.020
Why?
Ultraviolet Rays
1
1996
198
0.020
Why?
Intracellular Fluid
1
1994
42
0.020
Why?
GTP-Binding Proteins
1
1996
142
0.020
Why?
DNA Primers
1
1996
414
0.020
Why?
Cell Membrane Permeability
1
1994
102
0.020
Why?
Ion Transport
1
1994
70
0.020
Why?
Recombinant Proteins
1
1996
768
0.010
Why?
Base Sequence
1
1996
1704
0.010
Why?
Molecular Sequence Data
1
1996
2028
0.010
Why?
Signal Transduction
1
1996
1626
0.010
Why?

Visualizations


Bisognano's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department